Patient Characteristics
Patient no. | Age (y) | Sex | Histology | Grade | UICC (initial) | Date of initial diagnosis | Tumor sites on imaging (primary and metastatic) | SUVmax | |
---|---|---|---|---|---|---|---|---|---|
68Ga-FAPI-46 | 18F-FDG | ||||||||
1 | 58 | M | iCC | 3 | II | 01/2020 | Bone, lymph node | 14.3 | 6.3 |
2 | 79 | F | iCC | 3 | IIIA | 01/2021 | Liver | 17.5 | 5.1 |
3 | 45 | M | pCC | 2 | IIIC | 08/2020 | Liver | 14.5 | 8.0 |
4 | 44 | M | iCC | 3 | II | 07/2016 | Liver | 28.6 | 5.2 |
5 | 57 | F | dCC | 3 | IIIB | 03/2018 | Ductus hepaticus communis, peritoneal | 11.4 | 11.6 |
6 | 70 | M | pCC | 2 | II | 12/2019 | Liver, lymph node | 9.3 | 4.0 |
7 | 40 | F | iCC | 2 | IV | 04/2021 | Liver, peritoneal, lymph node | 25.4 | NA |
8 | 79 | F | dCC | 2 | IIB | 03/2019 | None | NA | NA |
9 | 54 | F | iCC | 2 | IIIA | 03/2021 | Lymph node | 9.8 | 12.6 |
10 | 65 | F | iCC | 2 | IIIB | 08/2020 | Lymph node | 7.7 | 9.2 |
UICC = Union for International Cancer Control; iCC = intrahepatic cholangiocarcinoma; pCC = perihilar cholangiocarcinoma; dCC = distal cholangiocarcinoma; NA = not available.
SUVmax was determined in hottest lesion for each tracer.